GSK re-launches OTC diet pill

The over-the-counter weight-loss drug Alli saw a return to drugstores this week after a year hiatus.

February 25, 2015

7:00 pm

GlaxoSmithKline announced Wednesday that its over-the-counter weight-loss pill Alli is available again in US stores after a nearly 12-month reprieve since it pulled all Alli bottles in late March 2014. The drugmaker voluntarily recalled the weight-loss products from US and Puerto Rico retailers after GSK suspected some of the packages had been tampered with and could contain counterfeit pills. The drugmaker had received inquiries from seven states that Alli packaging did not contain Alli product.

From Our Partners

Taking a patient-centric approach to privacy

Partner Content

Taking a patient-centric approach to privacy

This podcast will explore ways to deliver tailored content that activates, educates and empowers patients while prioritizing privacy and consent.

Living brands: How to build brands in the age of omnichannel

Partner Content

Living brands: How to build brands in the age of omnichannel

This podcast looks at how to leverage advancements in data, technology, AI and content development in order to become a Living Brand.

Partner Content

The new brand.com experience

How healthcare manufacturers can improve customer engagement, drive high-value activity and inform future strategy with conversational AI.

Shifting market trends are transforming how pharma marketers find, target and engage with patients and providers

Partner Content

Shifting market trends are transforming how pharma marketers find, target and engage with patients and providers

The Healthcare Marketers Trend Survey shows that, as far as channel usage goes, more growth occurred in newer tactics like non-linear video and streaming audio than in some of the more traditional ones.